[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Synthon International Holdings BV - Strategic SWOT Analysis Review

July 2021 | 26 pages | ID: S0969E481B4EN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Synthon International Holdings BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

Synthon International Holdings BV (Synthon) is an integrated pharmaceutical company which focuses on delivering affordable medicines through innovative science. The company undertakes the research, development, manufacture and distribution of generics, active pharmaceutical ingredients and biopharmaceutical products. It provides small molecule generic products in the therapeutic areas of allergy, anti-infective, cardiovascular, central nervous system, oncology, skeletal and urology. The company’s products are approved by regulatory agencies in over 90 countries. It operates research and development facilities and manufacturing facilities to carry out its operations. The company has presence in Chile, Czech Republic, Mexico, Russia, Spain, Argentina, South Korea, and the US. Synthon is headquartered in Nijmegen, the Netherlands.

Synthon International Holdings BV Key Recent Developments

Jan 07,2021: Synthon announces Anish Mehta appointed as Chief Executive Officer and member of the Board of Directors
Jan 07,2021: Synthon appoints Anish Mehta as chief executive officer and member of the board of directors

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
SECTION 1 - ABOUT THE COMPANY

Synthon International Holdings BV - Key Facts
Synthon International Holdings BV - Key Employees
Synthon International Holdings BV - Key Employee Biographies
Synthon International Holdings BV - Major Products and Services
Synthon International Holdings BV - History
Synthon International Holdings BV - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Synthon International Holdings BV - Business Description
Synthon International Holdings BV - SWOT Analysis
SWOT Analysis - Overview
Synthon International Holdings BV - Strengths
Synthon International Holdings BV - Weaknesses
Synthon International Holdings BV - Opportunities
Synthon International Holdings BV - Threats
Synthon International Holdings BV - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Synthon International Holdings BV, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Synthon International Holdings BV, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Synthon International Holdings BV, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Jan 07, 2021: Synthon appoints Anish Mehta as chief executive officer and member of the board of directors
Jan 07, 2021: Synthon announces Anish Mehta appointed as Chief Executive Officer and member of the Board of Directors

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Synthon International Holdings BV, Key Facts
Synthon International Holdings BV, Key Employees
Synthon International Holdings BV, Key Employee Biographies
Synthon International Holdings BV, Major Products and Services
Synthon International Holdings BV, History
Synthon International Holdings BV, Subsidiaries
Synthon International Holdings BV, Key Competitors
Synthon International Holdings BV, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Synthon International Holdings BV, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Synthon International Holdings BV, Recent Deals Summary

LIST OF FIGURES

Synthon International Holdings BV, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Synthon International Holdings BV, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021


More Publications